Akebia Therapeutics Inc. (AKBA)
1.90
-0.02 (-1.04%)
At close: Apr 01, 2025, 3:59 PM
1.93
1.37%
Pre-market: Apr 02, 2025, 04:04 AM EDT
Akebia Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 51.87M | 42.92M | 90.47M | 149.8M | 228.7M | 147.45M | 104.64M | 70.16M | 187.34M | 49.78M | 32.78M | 21.22M | 1.64M |
| Short-Term Investments | n/a | n/a | n/a | n/a | 39.99M | 245K | 217M | 247.64M | 73.01M | 88.68M | 76.14M | 11.34M | n/a |
| Long-Term Investments | n/a | n/a | 2.7M | 2.04M | 2.04M | 2.09M | 2.46M | 1.28M | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 37.38M | 12.42M | 5.37M | 49.75M | 37.98M | 75.98M | 21.8M | 2.27M | 1.28M | 1.38M | 305K | 1.2M | n/a |
| Receivables | 34.37M | 39.29M | 41.06M | 51.58M | 26.85M | 38.86M | 16.67M | 34.22M | 33.82M | n/a | 48K | n/a | 85.63K |
| Inventory | 16.24M | 15.69M | 21.76M | 38.2M | 61.02M | 116.35M | 114.25M | 1.00 | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 11.35M | 20.24M | 17.25M | 4.31M | n/a | 263K | 15.72M | 6.35M | n/a | 2.56M | 1.51M | n/a | n/a |
| Total Current Assets | 113.83M | 118.15M | 184.95M | 272.01M | 371.44M | 309.53M | 468.27M | 358.36M | 296.32M | 141.02M | 110.48M | 33.43M | 2.24M |
| Property-Plant & Equipment | 10.42M | 16.05M | 34.37M | 40.61M | 35.5M | 39.42M | 8.02M | 3.62M | 2.61M | 540K | 209.93K | 30.37K | n/a |
| Goodwill & Intangibles | 59.04M | 95.09M | 127.14M | 163.18M | 199.22M | 346.26M | 383.21M | -1.46M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 106.84M | 123.55M | 166.88M | 253.54M | 272.7M | 461.67M | 528.26M | 5.89M | 3.9M | 1.92M | 514.93K | 1.23M | n/a |
| Total Assets | 220.67M | 241.7M | 351.83M | 525.55M | 644.14M | 771.2M | 996.54M | 364.25M | 300.22M | 142.94M | 111M | 34.66M | 2.24M |
| Account Payables | 15.18M | 14.63M | 18.02M | 33.59M | 41.31M | 39.22M | 42.8M | 7M | 2.04M | 2.31M | 2.02M | 714K | 417.94K |
| Deferred Revenue | n/a | n/a | 3.74M | 20.91M | 15.21M | 39.83M | 56.98M | 84.91M | 81.97M | -8K | n/a | n/a | n/a |
| Short-Term Debt | n/a | 19.55M | 32M | 97.54M | n/a | n/a | 15M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 65.73M | 18.26M | 52.53M | 31.18M | 38.05M | 31.28M | 26.82M | 46.47M | 29K | 6.55M | n/a | 2.64M | 4.32M |
| Total Current Liabilities | 80.91M | 99.87M | 124.76M | 256.49M | 187.15M | 208.12M | 265.69M | 144.35M | 114.27M | 11.87M | 6.88M | 3.9M | 4.92M |
| Long-Term Debt | 3.55M | 71.2M | 91.56M | n/a | 96.38M | 75.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 185.39M | 48.98M | 57.47M | 139.11M | 63.03M | 31.87M | 32.58M | 2.61M | 2.51M | 74K | 32K | 0.00 | n/a |
| Total Long-Term Liabilities | 188.94M | 172.42M | 217.73M | 192.6M | 209.38M | 168.33M | 94.92M | 100.57M | 117.83M | 74K | 32K | 8K | n/a |
| Total Liabilities | 269.86M | 272.29M | 342.49M | 449.09M | 396.52M | 376.44M | 360.61M | 244.92M | 232.1M | 11.94M | 6.92M | 3.91M | 4.92M |
| Total Debt | 3.55M | 104.18M | 99.78M | 136.05M | 126.28M | 108.32M | 15M | n/a | 14K | 14K | n/a | 11.92K | n/a |
| Common Stock | 2K | 2K | 2K | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | 134.00 | 6.00 |
| Retained Earnings | -1.68B | -1.61B | -1.55B | -1.46B | -1.18B | -794.05M | -514.39M | -374.05M | -297.14M | -161.39M | -100.67M | -63.71M | -59.59M |
| Comprehensive Income | 6K | 6K | 6K | 6K | 13K | 0.00 | -261K | -442K | -42K | -234K | -56K | -1.28K | n/a |
| Shareholders Equity | -49.19M | -30.58M | 9.34M | 76.46M | 247.62M | 394.76M | 635.93M | 119.33M | 68.12M | 131M | 104.08M | 30.76M | -2.68M |
| Total Investments | n/a | 1.65M | 2.7M | 2.04M | 39.99M | 245K | 217M | 247.64M | 73.01M | 88.68M | 76.14M | 11.34M | n/a |